During the current pandemic, we have diverted resources and expertise into developing simple, low cost and scalable testing products for Sars-CoV-2.
These products are available for testing laboratories wishing to implement extraction and qRT-PCR protocols in their own labs or through our service facility.
Nonacus now offers the following:
- Fully supported workflow for nasopharyngeal swabs and other biofluids: A low cost and fast extraction process using a simple bead based protocol that allows rapid purification of viral RNA from swab samples and other biofluids
- Sensitive single and multiplex qRT-PCR assays for Sars-CoV-2: Validated for nasopharangeal swabs and other biofluids
- Service facility with capacity to process 2000 extractions per day: Highly automated processing ensures results are delivered quickly and efficiently.
VirPath – Bead Xtract Viral DNA/RNA Extraction kit:
This extraction kit is designed for the rapid and reliable isolation of viral DNA or RNA from nasopharyngeal swabs or other biofluids. The magnetic bead-based technology enables the purification of high-quality ribonucleic acid free from protein and other impurities required for downstream qRT-PCR. Fast, low cost and easily scaled up or down, the VirPath - Bead Xtract Viral DNA/RNA kit is ideally suited to Sars-CoV-2 testing.
VirPath - Sars-CoV-2 qRT-PCR kits:
Nonacus have developed both single and multiplex, one step qRT-PCR kits using proven primer and probe sequences targeting Sars-CoV-2.
VirPath - Sars-CoV-2 Single-Plex qRT-PCR kit:
This is a single-plex test which covers N1, N2 and RP assays defined by the US Centre for Disease Control (CDC) which have been extensively validated for the detection of Sars-CoV-2. The kit is suitable for customers with 1 or 2 colour systems and is provided with both positive and negative controls.
VirPath - Sars-CoV-2 Multiplex qRT-PCR kit:
This multiplex kit uses a combination of the best performing proven CDC and WHO assays and targets the nucleocapsid gene (assay N1), the envelope gene (assay E) of Sars-CoV-2 and the RPP30 gene (assay RP) used as an internal RNA extraction control. The kit is suitable for customers with 3, 4 or 5 colour systems and is provided with both positive and negative controls.
UK firm develops coronavirus spit test which could be done at home
Read an interview with Nonacus Limited in the Sunday Telegraph on how a partnership with Chronomics has led to the development of a spit test for COVID-19
|VirPath - Sars-CoV-2 qRT-PCR kit, 1,000 reactions||C3COV191|
|VirPath - Sars-CoV-2 qRT-PCR kit, 10,000 reactions||C3COV192|
|VirPath – Bead Xtract Viral DNA/RNA Extraction, 1,000 samples||C3COV193|
|VirPath – Bead Xtract Viral DNA/RNA Extraction kit, 10,000 samples||C3COV194|